Activity Details

0.75 AMA PRA Category 1 Credit
0.75 Contact Hour(s)
Released: June 20, 2018
Expires: June 1, 2019
45 minutes to complete

Accredited By

Global Education Group

Joint Providership Statement

This activity is jointly provided by Global Education Group and Strategic Consultants International.

Fee Information

There is no fee for participating in this educational activity.

Target Audience

Neurology physicians, NPs, PAs, and MS Nurses who are interested in the latest insights on the management of patients with multiple sclerosis.

Learning Objectives

At the conclusion of one or more of the proposed activities, participants will be better able to:

  • Describe the recently presented data on the treatment of relapsing remitting and progressive forms of multiple sclerosis (MS)
  • Explain how current management of patients with MS may be adapted to reflect the latest advances.

Activity Description

A series of four faculty video discussions. Each video highlights a different aspect of MS disease management

Statement of Educational Need

Management of MS has advanced dramatically over recent years, with new DMTs becoming available and increasingly, a recognition that ‘NEDA’ is a potential goal of therapy.  As these concepts continue to emerge it is essential that neurologists and MS nurses (and other healthcare providers) caring for patients with MS are fully apprised of recent data.

Importantly, in addition to the actual evidence, clinical interpretation of this information is vital.  To facilitate this, expert insight is necessary to provide a framework for consideration of if/how to amend management approaches in the light of new data and evidence, to improve knowledge and competence, and ultimately, patient care.


This activity comprises four individual video discussions. These may be accessed sequentially or as preferred.

Chapter 1. Current and ‘near future’ platform therapies for RRMS
Chapter 2. Highly active injectable DMTs (monoclonal antibodies) in RMS: New data
Chapter 3. Progressive MS
Chapter 4. MS outcomes and predictors of progression

Evaluation and post-test


Patricia Coyle, MD
Vice Chair, Department of Neurology, Director, MS Comprehensive Care Center,
Stony Brook University Hospital, East Setauket, New York

Stephen Krieger, MD
Associate Professor of Neurology, Corinne Goldsmith Dickinson Center for MS
Director, Neurology Residency Program, Icahn School of Medicine at Mount Sinai, New York

Gabriel Pardo, MD
Director, OMRF Multiple Sclerosis Center of Excellence
Associate Member, Arthritis & Clinical Immunology Research Program
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma

Jerry Wolinsky, MD
Emeritus Professor in Neurology
McGovern Medical School, part of UTHealth
The University of Texas Health Science Center at Houston, Houston, Texas

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Patricia Coyle, MD
Consultant/Independent Contractor:
Accordant, Acorda, Bayer, Biogen, Celgene, EMD Serono, Genentech/Roche, Novartis, Sanofi-Genzyme
Grant/Research Support:
Actelion, Genentech/Roche, MedDay, Novartis

Stephen Krieger, MD
Consultant/Independent Contractor:
Acorda, Biogen, Celgene, EMD Serono, Genentech, Genzyme, Mallincrodt, Novartis, Teva, TG therapeutic

Gabriel Pardo, MD
Consultant/Independent Contractor:
Biogen, EMD Serono, Genentech, Genzyme, Novartis, Teva

Jerry Wolinsky, MD
Consultant/Independent Contractor:
AbbVie, Actelion, Biogen, Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma A/S, GeNeuro, Genentech/Roche, McDonnel Boehnen Hulbert & Berghoff, MedDay Pharmaceuticals, Novartis Pharmaceuticals, Otsuka, PTC Therapeutics, Sanofi-Genzyme
AcademicCME, ACTRIMS, Alkermes, CMSC, ECTRIMS, France Foundation, Masters MS (Annenberg Center for Health Sciences at Eisenhower), PlatformQ Health Education, PRIME, Strategic Consultants International, Society for Clinical Trials, WebMD
For out licensed monoclonal antibodies through UTHealth to Millipore (Chemicon International) Corporation

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Lindsay Borvasnky
Nothing to disclose

Ashley Marostica
Nothing to disclose

Liddy Knight
Nothing to disclose

Ian Morgan
Nothing to disclose

Accreditation Statement

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Strategic Consultants International (SCI). Global is accredited by the ACCME to provide continuing medical education for physicians.

Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation .

Designation of Credit

Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit Designation
This educational activity for 0.75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

In order to receive credit for this activity, the participant must review the materials, complete the post-activity test with a pass mark of 65% or greater and complete the evaluation and credit request.

Statement of Commercial Support

This activity is supported by an educational grant from Genentech, Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Strategic Consultants International (SCI) do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information for Questions About the Activity

For information about the accreditation of this program, please contact Global at 303-395-1782 or

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.